Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques. We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health.
In the evolving landscape of global botanical wellness, Wu Jia Pi (Cortex Acanthopanacis) has emerged as a cornerstone ingredient. As a versatile adaptogen, its presence in the international market has transitioned from traditional pharmacopeias to mainstream health supplements and functional beverages. High-quality Wu Jia Pi exporters are now central to a multi-billion dollar nutraceutical industry, driven by the increasing demand for natural remedies that support joint health and immune resilience.
The industrial demand for Wu Jia Pi concentrated granules has seen a sharp 25% year-on-year increase in North American and European markets. Research-intensive medical institutions are seeking standardized extracts that offer consistent therapeutic profiles, a requirement that only top-tier exporters from the Sichuan region can satisfy through advanced extraction technologies.
The global TCM market is undergoing a "Technological Renaissance." No longer confined to dried herbs, the industry is shifting toward precision extraction. As a premier Wu Jia Pi exporter, we observe three major trends:
International procurement managers for pharmacies and clinics are prioritizing the "Efficiency of the B2B Supply Chain." Wu Jia Pi is widely sought after in Germany, the UK, and the USA for its applications in rheumatic management and vitality formulas. Procurement needs have shifted toward "Just-in-Time" inventory models, requiring exporters to have robust logistics and local warehousing support—something Neo-Green Herbs provides through our US-based infrastructure.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation. As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
Our localized application scenarios include providing customized Wu Jia Pi blends for European rehabilitation centers and dietary supplement brands. Our AI-driven quality control system ensures that every batch of exporter-grade Wu Jia Pi meets the stringent heavy metal and pesticide residue standards of the international market.
The role of a China High-Quality Wu Jia Pi exporter transcends simple shipping; it involves the harmonization of ancient wisdom with modern pharmaceutical standards. In the industrial sector, Wu Jia Pi is used extensively as a base ingredient for various pharmacological applications. Global manufacturing plants utilize our extract for high-end capsule production and concentrated liquid tonics. As exporters, we emphasize the "Total Quality Management" approach, ensuring that our Sichuan-grown Wu Jia Pi retains its bioactive compounds, such as syringin and eleutherosides, through low-temperature vacuum extraction.
Furthermore, the development of Wu Jia Pi in the global market is deeply linked to the trend of clean-label products. Consumers in the APAC and MENA regions are increasingly avoiding synthetic compounds, turning instead to time-tested botanicals. This has opened a massive corridor for B2B supply chains to provide not just a product, but a certified health solution. By leveraging our position as a "National Key Leading Enterprise," we offer our partners a security of supply and pricing stability that few other exporters can match.
Our AI-enhanced manufacturing facility uses big data to predict harvest cycles and potency levels, ensuring that when a medical institution or wholesale distributor orders from us, they receive a product optimized for efficacy. This tech-centric approach is what defines the future of TCM exports from China to the world.